Jones RN and Biedenbach DJ |
Antimicrobial activity of RU-66647, a new ketolide. |
1997 Jan-Feb |
Diagn. Microbiol. Infect. Dis. |
pmid:9127099
|
Roord JJ et al. |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124837
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Kavukçu S et al. |
Hypothermia from azithromycin. |
1997 |
J. Toxicol. Clin. Toxicol. |
pmid:9120898
|
Dawson CR et al. |
A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. |
1997 |
Clin. Infect. Dis. |
pmid:9114186
|
Tarlow MJ et al. |
Future indications for macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109159
|
Block SL |
Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109158
|
Tarlow MJ |
Macrolides in the management of streptococcal pharyngitis/tonsillitis. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109157
|
Nightingale CH |
Pharmacokinetics and pharmacodynamics of newer macrolides. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109156
|
McCracken GH |
Microbiologic activity of the newer macrolide antibiotics. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109155
|
Klein JO |
History of macrolide use in pediatrics. |
1997 |
Pediatr. Infect. Dis. J. |
pmid:9109154
|
Ficnar B et al. |
Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group. |
1997 |
J Chemother |
pmid:9106016
|
Fietta A et al. |
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. |
1997 |
J Chemother |
pmid:9106014
|
Fietta A et al. |
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. |
1997 |
J Chemother |
pmid:9106013
|
Kitamura K et al. |
[Pharmacokinetic and clinical evaluation of azithromycin in the pediatric field]. |
1997 |
Jpn J Antibiot |
pmid:9100081
|
Tajima T et al. |
[Pharmacokinetic, bacteriological and clinical studies on azithromycin in children]. |
1997 |
Jpn J Antibiot |
pmid:9100080
|
Handsfield HH et al. |
Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. |
1994 Mar-Apr |
Sex Transm Dis |
pmid:9071422
|
Pascual A et al. |
Azithromycin uptake by tissue cultured epithelial cells. |
1997 |
J. Antimicrob. Chemother. |
pmid:9069561
|
Herrera-Insúa I et al. |
Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063667
|